FDA Clearance Tracker · P100016-S017
CT LUCIA 621P
Last checked: Nov 20, 2026Latest source record: Oct 2, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 2, 2023
Approved
Time to decision
143 days
Received May 12, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100016-S017
- Device name
- CT LUCIA 621P
- Applicant
- Carl Zeiss Meditec Production, LLC
- Applicant location
- Ontario, CA
- Received
- May 12, 2023
- Decided
- Oct 2, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100016
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for an extension of the shelf life for the subject CT LUCIA 621P intraocular lens (IOL) in BLUESERT injector from 18-months to 36-months.
Source documents
Other decisions for Carl Zeiss Meditec Production, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.